JP7332581B2 - 胃内圧変化を測定する装置 - Google Patents
胃内圧変化を測定する装置 Download PDFInfo
- Publication number
- JP7332581B2 JP7332581B2 JP2020507016A JP2020507016A JP7332581B2 JP 7332581 B2 JP7332581 B2 JP 7332581B2 JP 2020507016 A JP2020507016 A JP 2020507016A JP 2020507016 A JP2020507016 A JP 2020507016A JP 7332581 B2 JP7332581 B2 JP 7332581B2
- Authority
- JP
- Japan
- Prior art keywords
- balloon
- catheter
- pressure
- lumen
- balloons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002496 gastric effect Effects 0.000 title description 43
- 210000002784 stomach Anatomy 0.000 claims description 148
- 230000030135 gastric motility Effects 0.000 claims description 73
- 239000000463 material Substances 0.000 claims description 65
- 239000012530 fluid Substances 0.000 claims description 43
- 235000013305 food Nutrition 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 30
- 210000001198 duodenum Anatomy 0.000 claims description 29
- 210000000813 small intestine Anatomy 0.000 claims description 27
- 241000282414 Homo sapiens Species 0.000 claims description 25
- 239000004814 polyurethane Substances 0.000 claims description 24
- 229920002635 polyurethane Polymers 0.000 claims description 21
- 229920003023 plastic Polymers 0.000 claims description 12
- 239000004033 plastic Substances 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 11
- 230000001419 dependent effect Effects 0.000 claims description 7
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 68
- 230000008602 contraction Effects 0.000 description 55
- 229960004126 codeine Drugs 0.000 description 34
- 230000000694 effects Effects 0.000 description 34
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 34
- 238000010586 diagram Methods 0.000 description 33
- 239000004698 Polyethylene Substances 0.000 description 32
- 229920000573 polyethylene Polymers 0.000 description 32
- 230000035611 feeding Effects 0.000 description 30
- 238000000034 method Methods 0.000 description 30
- 230000033001 locomotion Effects 0.000 description 27
- 230000008901 benefit Effects 0.000 description 25
- 238000009530 blood pressure measurement Methods 0.000 description 24
- 238000001802 infusion Methods 0.000 description 24
- 238000005259 measurement Methods 0.000 description 24
- 239000000902 placebo Substances 0.000 description 24
- 229940068196 placebo Drugs 0.000 description 24
- 235000016709 nutrition Nutrition 0.000 description 23
- 206010000060 Abdominal distension Diseases 0.000 description 22
- 230000030136 gastric emptying Effects 0.000 description 22
- 208000024891 symptom Diseases 0.000 description 22
- 208000024330 bloating Diseases 0.000 description 21
- 201000006549 dyspepsia Diseases 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 21
- 229920000126 latex Polymers 0.000 description 21
- 239000004816 latex Substances 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 20
- -1 polyethylene Polymers 0.000 description 19
- 238000011084 recovery Methods 0.000 description 19
- 235000015097 nutrients Nutrition 0.000 description 18
- 206010028813 Nausea Diseases 0.000 description 17
- 230000008693 nausea Effects 0.000 description 17
- 230000036186 satiety Effects 0.000 description 17
- 235000019627 satiety Nutrition 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 102100040299 Guided entry of tail-anchored proteins factor 1 Human genes 0.000 description 15
- 101001038390 Homo sapiens Guided entry of tail-anchored proteins factor 1 Proteins 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 210000003238 esophagus Anatomy 0.000 description 12
- 206010021518 Impaired gastric emptying Diseases 0.000 description 11
- 210000000214 mouth Anatomy 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 206010020751 Hypersensitivity Diseases 0.000 description 9
- 208000026935 allergic disease Diseases 0.000 description 8
- 230000001186 cumulative effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000009610 hypersensitivity Effects 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000035764 nutrition Effects 0.000 description 8
- 210000001187 pylorus Anatomy 0.000 description 8
- 230000001960 triggered effect Effects 0.000 description 8
- 208000018522 Gastrointestinal disease Diseases 0.000 description 7
- 229920002614 Polyether block amide Polymers 0.000 description 7
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 7
- 229920001651 Cyanoacrylate Polymers 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 208000001288 gastroparesis Diseases 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 208000028399 Critical Illness Diseases 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 230000000291 postprandial effect Effects 0.000 description 5
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- 229920002725 thermoplastic elastomer Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 235000019525 fullness Nutrition 0.000 description 4
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 230000036972 phasic contraction Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000036977 tonic contraction Effects 0.000 description 4
- 206010059186 Early satiety Diseases 0.000 description 3
- 206010061958 Food Intolerance Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000004899 motility Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000019553 satiation Nutrition 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 208000025966 Neurological disease Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940124558 contraceptive agent Drugs 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004968 inflammatory condition Effects 0.000 description 2
- 238000002307 isotope ratio mass spectrometry Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000002690 local anesthesia Methods 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000001991 pathophysiological effect Effects 0.000 description 2
- 230000008289 pathophysiological mechanism Effects 0.000 description 2
- 230000007310 pathophysiology Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 229940072358 xylocaine Drugs 0.000 description 2
- VQJMAIZOEPPELO-KYGIZGOZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol hydrochloride Chemical compound Cl.CO[C@]12CC[C@@]3(C[C@@H]1C(C)(O)CCC(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 VQJMAIZOEPPELO-KYGIZGOZSA-N 0.000 description 1
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 description 1
- HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 239000004821 Contact adhesive Substances 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000784713 Cupido Species 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 description 1
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000008279 Dumping Syndrome Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000000624 Esophageal and Gastric Varices Diseases 0.000 description 1
- 206010017788 Gastric haemorrhage Diseases 0.000 description 1
- 206010052405 Gastric hypomotility Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019670 Hepatic function abnormal Diseases 0.000 description 1
- 206010062530 Increased bronchial secretion Diseases 0.000 description 1
- 239000004824 Multi-part adhesive Substances 0.000 description 1
- 239000004825 One-part adhesive Substances 0.000 description 1
- 102000018886 Pancreatic Polypeptide Human genes 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010035669 Pneumonia aspiration Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000032395 Post gastric surgery syndrome Diseases 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000004823 Reactive adhesive Substances 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 1
- 206010056091 Varices oesophageal Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DTTPWCNKTMQMTE-TYNNPWLESA-N [(1R,2S,3S,4S,5R,6S,8R,12S,13S,16R,19S,20R,21S)-14-ethyl-2-hydroxy-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.12,5.01,13.03,8.08,12.016,20]docosan-21-yl] acetate Chemical compound CCN1C[C@]2(C)CC[C@H](OC)[C@]34[C@@H]2[C@H](OC(C)=O)[C@@]2(OCO[C@@]22C[C@H](OC)[C@H]5C[C@]3(O)[C@@H]2[C@H]5OC)[C@@H]14 DTTPWCNKTMQMTE-TYNNPWLESA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- UPNUIXSCZBYVBB-JVFUWBCBSA-N alvimopan Chemical compound C([C@@H](CN1C[C@@H]([C@](CC1)(C)C=1C=C(O)C=CC=1)C)C(=O)NCC(O)=O)C1=CC=CC=C1 UPNUIXSCZBYVBB-JVFUWBCBSA-N 0.000 description 1
- 229960004516 alvimopan Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 201000009807 aspiration pneumonia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 description 1
- 229960000910 bethanechol Drugs 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- DTTPWCNKTMQMTE-UHFFFAOYSA-N delphelatine Natural products O1COC2(C3C4OC)CC(OC)C4CC3(O)C34C(OC)CCC5(C)CN(CC)C4C21C(OC(C)=O)C53 DTTPWCNKTMQMTE-UHFFFAOYSA-N 0.000 description 1
- WNIGHBYIOLQQSJ-UHFFFAOYSA-N deltaline Natural products CCN1CC2(COC)CCC(O)C34C2C(OC(=O)C)C5(OCOC56CC(OC)C7CC3(O)C6C7O)C14 WNIGHBYIOLQQSJ-UHFFFAOYSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 208000024170 esophageal varices Diseases 0.000 description 1
- 201000010120 esophageal varix Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000002599 gastric fundus Anatomy 0.000 description 1
- 239000003629 gastrointestinal hormone Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000003910 liver physiology Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000004457 myocytus nodalis Anatomy 0.000 description 1
- 230000003183 myoelectrical effect Effects 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- WWZKQHOCKIZLMA-WKHKRNGSSA-N octanoic acid Chemical compound CCCC[13CH2][13CH2][13CH2][13C](O)=O WWZKQHOCKIZLMA-WKHKRNGSSA-N 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000009158 reflex pathway Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036390 resting membrane potential Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000037046 slow wave activity Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960004380 tramadol Drugs 0.000 description 1
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4238—Evaluating particular parts, e.g. particular organs stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0003—Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/008—Sensor means, e.g. for sensing reflux, acidity or pressure
- A61J15/0084—Sensor means, e.g. for sensing reflux, acidity or pressure for sensing parameters related to the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0001—Catheters; Hollow probes for pressure measurement
- A61M2025/0003—Catheters; Hollow probes for pressure measurement having an additional lumen transmitting fluid pressure to the outside for measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1015—Multiple balloon catheters having two or more independently movable balloons where the distance between the balloons can be adjusted, e.g. two balloon catheters concentric to each other forming an adjustable multiple balloon catheter system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1712812.5A GB201712812D0 (en) | 2017-08-10 | 2017-08-10 | Apparatus for measuring pressure changes in a stomach |
| GB1712812.5 | 2017-08-10 | ||
| EP17192538.1 | 2017-09-22 | ||
| EP17192538 | 2017-09-22 | ||
| EP18172298 | 2018-05-15 | ||
| EP18172298.4 | 2018-05-15 | ||
| PCT/EP2018/071587 WO2019030312A1 (en) | 2017-08-10 | 2018-08-09 | APPARATUS FOR MEASURING PRESSURE VARIATIONS IN STOMACH |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020530343A JP2020530343A (ja) | 2020-10-22 |
| JP2020530343A5 JP2020530343A5 (https=) | 2021-09-24 |
| JP7332581B2 true JP7332581B2 (ja) | 2023-08-23 |
Family
ID=63079938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020507016A Active JP7332581B2 (ja) | 2017-08-10 | 2018-08-09 | 胃内圧変化を測定する装置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11813070B2 (https=) |
| EP (1) | EP3664706B1 (https=) |
| JP (1) | JP7332581B2 (https=) |
| CN (1) | CN111447871B (https=) |
| ES (1) | ES2904454T3 (https=) |
| PL (1) | PL3664706T3 (https=) |
| WO (1) | WO2019030312A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11045128B2 (en) | 2017-06-03 | 2021-06-29 | Sentinel Medical Technologies, LLC | Catheter for monitoring intra-abdominal pressure |
| CN112585691A (zh) | 2018-05-15 | 2021-03-30 | Vipun医疗股份有限公司 | 用于确定胃运动性和用于喂饲患者的系统 |
| US12350455B2 (en) * | 2018-08-29 | 2025-07-08 | Jonathan SOVEROW | Angioplasty balloon snare |
| US11672457B2 (en) | 2018-11-24 | 2023-06-13 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
| US11779263B2 (en) | 2019-02-08 | 2023-10-10 | Sentinel Medical Technologies, Llc. | Catheter for monitoring intra-abdominal pressure for assessing preeclampsia |
| EP4009860B1 (en) | 2019-08-08 | 2024-07-24 | Sentinel Medical Technologies, LLC | Cable for use with pressure monitoring catheters |
| US11617543B2 (en) * | 2019-12-30 | 2023-04-04 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
| CN114469745A (zh) * | 2020-10-23 | 2022-05-13 | 深圳迈瑞生物医疗电子股份有限公司 | 胃管组件 |
| CN114469744A (zh) * | 2020-10-23 | 2022-05-13 | 深圳迈瑞生物医疗电子股份有限公司 | 胃管组件 |
| CN114469743A (zh) * | 2020-10-23 | 2022-05-13 | 深圳迈瑞生物医疗电子股份有限公司 | 胃管组件 |
| US20240306929A1 (en) | 2021-01-18 | 2024-09-19 | Vipun Medical Nv | Method and system for determining whether a balloon catheter is positioned in the stomach of a person |
| CN113476312A (zh) * | 2021-08-20 | 2021-10-08 | 上海市第一人民医院 | 一种多功能水囊式胃造瘘管 |
| JP7015602B1 (ja) | 2021-11-04 | 2022-02-14 | 株式会社Arblet | 生体情報測定装置 |
| CN113940653B (zh) * | 2021-12-20 | 2022-04-12 | 广州国家实验室 | 用于检测体腔压力的气压调节机构、检测导管及检测装置 |
| IL316569A (en) * | 2022-05-04 | 2024-12-01 | Ardis Ltd | Devices and methods for diagnosing medical conditions |
| US20240008720A1 (en) * | 2022-07-06 | 2024-01-11 | Gyrus Acmi, Inc. D/B/C Olympus Surgical Technologies America | Elongate endoscopic covering |
| US20240050716A1 (en) * | 2022-08-12 | 2024-02-15 | Jihad Ali Mustapha | Balloon catheter with biasing member |
| CN115581447B (zh) * | 2022-10-09 | 2023-05-02 | 宁波迈达医疗仪器有限公司 | 用于固态测压导管性能的智能校准装置及其校准方法 |
| CN116115209B (zh) * | 2023-01-18 | 2024-09-20 | 大连理工大学 | 一种胃内动压监测与受控激励装置 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515036A (ja) | 1996-07-23 | 2000-11-14 | シメッド ライフ システムズ インコーポレイテッド | 胃腸病巣処置に好適なカテーテル用高コンプライアンス高強度バルーン |
| JP2008049160A (ja) | 2006-08-25 | 2008-03-06 | Pulsion Medical Systems Ag | 経腸フィードカテーテルおよび患者の腹腔内圧を測定するための装置 |
| WO2008154450A1 (en) | 2007-06-08 | 2008-12-18 | Valentx, Inc. | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
| US20090082644A1 (en) | 2007-03-15 | 2009-03-26 | Jiayi Li | Devices, Systems, Kits and Methods for Treatment of Obesity |
| US20120277586A1 (en) | 2011-04-26 | 2012-11-01 | Bosel Christopher D | Feeding tube having echogenic tip |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4367740A (en) * | 1980-12-10 | 1983-01-11 | Evanoski Iii Constant J | Combination catheter cystometer system and gastric feeding device |
| US5395331A (en) * | 1992-04-27 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Retrograde coronary sinus catheter having a ribbed balloon |
| US5370618A (en) * | 1992-11-20 | 1994-12-06 | World Medical Manufacturing Corporation | Pulmonary artery polyurethane balloon catheter |
| US5433216A (en) * | 1993-06-14 | 1995-07-18 | Mountpelier Investments, S.A. | Intra-abdominal pressure measurement apparatus and method |
| US20050015048A1 (en) * | 2003-03-12 | 2005-01-20 | Chiu Jessica G. | Infusion treatment agents, catheters, filter devices, and occlusion devices, and use thereof |
| EP1695684B1 (en) | 2005-02-25 | 2012-02-15 | Pulsion Medical Systems AG | Enteral feeding catheter, computer system and computer program for operating the feeding catheter |
| WO2008066943A2 (en) | 2006-04-25 | 2008-06-05 | Lumerx, Inc. | Light-wand and balloon catheters |
| US8109903B2 (en) * | 2007-05-21 | 2012-02-07 | Smart Medical Systems Ltd. | Catheter including a bendable portion |
| US9561066B2 (en) * | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
| US9622670B2 (en) * | 2010-07-09 | 2017-04-18 | Potrero Medical, Inc. | Method and apparatus for pressure measurement |
| US9554750B2 (en) | 2012-01-18 | 2017-01-31 | Medspira Llc | Motility manometer priming manifold system with icon-based user interface and wireless connectivity |
| WO2016070032A1 (en) * | 2014-10-30 | 2016-05-06 | Neurotronic, Inc. | Chemical ablation and method of treatment for various diseases |
| US9005123B2 (en) * | 2013-02-15 | 2015-04-14 | Pneumoflex Systems, Llc | Device with active valve to block emesis and reflux blockage device and associated system and method |
| MX2016007236A (es) * | 2013-12-04 | 2016-08-04 | Obalon Therapeutics Inc | Sistemas y metodos para ubicar y/o caracterizar dispositivos intragastricos. |
| US10898091B2 (en) * | 2015-02-02 | 2021-01-26 | Northwestern University | Systems, methods, and apparatus for esophageal panometry |
| US10391275B2 (en) * | 2015-11-17 | 2019-08-27 | Potrero Medical, Inc. | Systems, devices and methods for draining and analyzing bodily fluids |
| US10537453B2 (en) | 2015-12-16 | 2020-01-21 | Obalon Therapeutics, Inc. | Intragastric device with expandable portions |
| WO2017184843A1 (en) * | 2016-04-22 | 2017-10-26 | The Regents Of The University Of California | Enteral drug delivery system |
| CN108348463A (zh) * | 2016-05-13 | 2018-07-31 | 泰克利森有限公司 | 用于治疗肝脏组织的方法 |
| CN106691866B (zh) * | 2017-02-09 | 2024-03-08 | 北京雅果科技有限公司 | 多功能胃管及其压力检测单元的初始化方法 |
-
2018
- 2018-08-09 JP JP2020507016A patent/JP7332581B2/ja active Active
- 2018-08-09 EP EP18749388.7A patent/EP3664706B1/en active Active
- 2018-08-09 US US16/637,337 patent/US11813070B2/en active Active
- 2018-08-09 ES ES18749388T patent/ES2904454T3/es active Active
- 2018-08-09 CN CN201880065442.0A patent/CN111447871B/zh not_active Expired - Fee Related
- 2018-08-09 PL PL18749388T patent/PL3664706T3/pl unknown
- 2018-08-09 WO PCT/EP2018/071587 patent/WO2019030312A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515036A (ja) | 1996-07-23 | 2000-11-14 | シメッド ライフ システムズ インコーポレイテッド | 胃腸病巣処置に好適なカテーテル用高コンプライアンス高強度バルーン |
| JP2008049160A (ja) | 2006-08-25 | 2008-03-06 | Pulsion Medical Systems Ag | 経腸フィードカテーテルおよび患者の腹腔内圧を測定するための装置 |
| US20090082644A1 (en) | 2007-03-15 | 2009-03-26 | Jiayi Li | Devices, Systems, Kits and Methods for Treatment of Obesity |
| WO2008154450A1 (en) | 2007-06-08 | 2008-12-18 | Valentx, Inc. | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
| US20120277586A1 (en) | 2011-04-26 | 2012-11-01 | Bosel Christopher D | Feeding tube having echogenic tip |
Also Published As
| Publication number | Publication date |
|---|---|
| US11813070B2 (en) | 2023-11-14 |
| EP3664706A1 (en) | 2020-06-17 |
| EP3664706B1 (en) | 2021-10-13 |
| CN111447871A (zh) | 2020-07-24 |
| WO2019030312A1 (en) | 2019-02-14 |
| JP2020530343A (ja) | 2020-10-22 |
| CN111447871B (zh) | 2023-02-28 |
| PL3664706T3 (pl) | 2022-02-14 |
| US20210369185A1 (en) | 2021-12-02 |
| ES2904454T3 (es) | 2022-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7332581B2 (ja) | 胃内圧変化を測定する装置 | |
| US10758135B2 (en) | Method and apparatus for pressure measurement | |
| EP1267711B1 (en) | Apparatus for measuring the compliance of a sphincter | |
| US10864323B2 (en) | Modulated drug delivery | |
| US9005124B2 (en) | Device to block emesis and reflux and associated system and method | |
| US9005123B2 (en) | Device with active valve to block emesis and reflux blockage device and associated system and method | |
| ES2982182T3 (es) | Dispositivo intragástrico con autodesinflado | |
| AU2001245990A1 (en) | Apparatus for measuring esophageal sphincter compliance | |
| CN102333562A (zh) | 肠道喂养装置、包括它的系统、方法及其应用 | |
| CN104688546A (zh) | 一种防止误吸的胃管 | |
| US20140235957A1 (en) | Device with passive valve to block emesis and/or reflux and associated system and method | |
| WO2017160270A1 (en) | Modulated drug delivery | |
| CN213048922U (zh) | 一种新型食管扩张球囊导管 | |
| CN205268627U (zh) | 一种贲门封堵式鼻胃管 | |
| CN112546403A (zh) | 一种具有核心温度检测和防食管反流作用的胃管 | |
| CN202332043U (zh) | 一种三腔两囊管止血训练模型 | |
| CN115317212A (zh) | 一种胃内水球装置 | |
| CN221751925U (zh) | 一种可监测食道温度的胃管 | |
| CN115177846B (zh) | 一种无张力性感觉球囊及应用该球囊的装置 | |
| CN222533916U (zh) | 一种用于食管狭窄扩张治疗的胃肠管装置 | |
| CN221711930U (zh) | 一种三腔双气囊食道压监测管 | |
| CN210096414U (zh) | 一种多功能胃肠管 | |
| CN109330897A (zh) | 一种经鼻胃肠留置管固定器 | |
| Decker et al. | Enteroscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210720 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210810 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20211115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20211115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220112 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220303 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220712 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220915 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220916 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221215 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230313 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230405 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230712 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230810 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7332581 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |